[144] TaskUs, Inc. SEC Filing

Rhea-AI Filing Summary

TaskUs (TASK) has a Form 144 notice disclosing a proposed sale of 24,233 common shares with an aggregate market value of $412,930.32. The shares are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/11/2025. The filing shows the shares were acquired on 08/05/2025 as restricted stock units granted by the issuer. Total shares outstanding reported in the notice are 34,843,287. The filer reports "Nothing to Report" for securities sold in the past three months and includes the standard representation that the seller does not possess undisclosed material adverse information.

Insights

Securities/Financial Analyst

TL;DR: Small insider sale of vested RSUs, disclosed via Form 144; not likely material to valuation.

The filing shows an insider intends to sell 24,233 shares acquired as restricted stock units five days earlier, with an aggregate market value of $412,930.32 and a listed broker executing the sale on NASDAQ. Compared with the reported 34,843,287 shares outstanding, this position is modest in absolute and relative size, suggesting limited market impact. The filing also confirms no reported sales in the prior three months and includes the usual attestation regarding material nonpublic information.

Corporate Governance Expert

TL;DR: Compliance disclosure is in order; timing indicates sale of recently vested equity rather than long-term disposition.

The notice documents a sale of RSUs acquired on 08/05/2025 and listed for sale with an approximate date of 08/11/2025 through a named broker. This pattern commonly reflects routine disposition of recently vested awards. The filer has certified they do not possess undisclosed material adverse information and reported no other sales in the past three months, which aligns with disclosure expectations under Rule 144. No evidence in the form indicates regulatory or governance concerns beyond the routine insider sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	24233	412930.32	34843287	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/05/2025	Restricted Stock Units	Issuer			24233	08/05/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TaskUs (TASK) Form 144 disclose?

The notice discloses a proposed sale of 24,233 common shares valued at $412,930.32, to be sold on NASDAQ through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/11/2025.

How were the shares being sold acquired?

The filing states the shares were acquired on 08/05/2025 as Restricted Stock Units (RSUs) granted by the issuer.

How many TaskUs shares are outstanding according to the notice?

The Form 144 reports 34,843,287 shares outstanding.

Has the seller reported other sales in the past three months?

The filing indicates "Nothing to Report" for securities sold during the past three months.

What representations does the filer make in the Form 144?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.